Encapsulation of Bowman-Birk soybean proteinase inhibitor within zwitterionic phospholipid multilamellar vesicles

Journal of Drug Delivery Science and Technology

Volumn 16, Issue 4, 2006, Pages 301-306

  Balkina, A S ^a   Selischeva, A A ^a   Sorokoumova, G M ^b   Ollivon, M ^c   Larionova, N I ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b MIREA RUSSIAN TECHNOLOGICAL UNIVERSITY   (Russian Federation)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Delivery; Liposomes; Phosphatidylcholine; Phosphatidylethanolamine; Proteoliposomes; Soybean proteinase inhibitor of Bowman Birk type

Indexed keywords

AMPHOLYTE; ANTHRACENE; BOWMAN BIRK INHIBITOR; DETERGENT; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; RHODAMINE B;

ALPHA HELIX; ARTICLE; CONFOCAL LASER MICROSCOPY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENCAPSULATION; FLUORESCENCE; LIPID BILAYER; PARTICLE SIZE; PHOSPHOLIPID VESICLE; PROTEOLIPOSOME; SOYBEAN; SURFACE PROPERTY;

EID: 33748638243     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(06)50054-1     Document Type: Article

References (42)

1. BIRK Y. - The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans. - Int. J. Pept. Protein Res., 25, 113-131, 1985.
2. KENNEDY A.R. - Anticarcinogenic activity of protease inhibitors: Overview - In: Protease Inhibitors as Cancer Chemoprotective Agents, W. Troll and A. Kennedy Ed., Plenum Press, N.Y., London, 1993, pp. 9-64.
3. GLADYSHEVA I.P., MOROZ N.A., KAMAKOVA T.A., NEMTSOVA E.R., YAKUBOVSKAYA R.I., LARIONOVA N.I. - Immunoconjugates of soybean Bowman-Birk protease inhibitor as targeted antitumor polymeric agents. - J. Drug Target, 9, 303-316, 2001.
4. WARE J.H., WAN X.S., NEWBERNE P., KENNEDY A.R. - Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis. - Dig. Dis. Sci., 44, 986-990, 1999.
5. KENNEDY A.R. - The Bowman-Birk inhibitor from soybeans as anticarcinogenic agent. - Am. J. Clin. Nutr., 68, 1406S-1412S, 1998.
6. ROSTAMI A., KENNEDY A.R. - Use of Bowman Birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases. - US Patent 6,767,564, 2004.
7. ARMSTRONG W.B., KENNEDY A.R., WAN X.S., ATIBA J., MCLAREN C.E., MEYSKENS F.L. Jr. - Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia. - Cancer Epidemiol. Biomark. Prev., 9, 43-47, 2000.
8. WANG JIFENG, NIU JIANZHAO, FU MIN - Novel medicinal use of proteinase inhibitor for preventing and curing lung disease. - Patent CN 1488402, 2004.
9. BARRATT G. - Colloidal drug carriers: achievements and perspectives. - Cell. Mol. Life Sci., 60, 21-37, 2003.
10. TORCHILIN V.P. - Recent advances with liposomes as pharmaceutical carriers. - Nature Reviews, 4, 145-160, 2005.
11. LARIONOVA N.I., MOROZ N.A., TYURINA O.P. - Molecular design, characterization and pharmacological activity of conjugates of protein proteinase inhibitors. - STP Pharma Sci., 9, 67-82, 1999.
12. MALYKH E.V., TIOURINA O.P. and LARIONOVA N.I. - Acylation of Bowman-Birk soybean proteinase inhibitor by unsaturated fatty acid derivatives. - Biochemistry (Moscow), 66, 444-448, 2001.
13. LARIONOVA N.V., MALYKH E.V., VILLEMSON A.L., KRASOTA A.J., DUCHENE D., OLLIVON M., GERNET M.V., BELOUSOVA R.V., SHEN W.C., LARIONOVA N.I. - Effect of membranotropic and mucoadhesive formulations of protein proteinase inhibitors on bovine herpes virus-1 reproduction. - Int. J. Pharm., 256, 191-198, 2003.
14. BALKINA A.S., SELISCHEVA A.A., SOROKOUMOVA G.M., LARIONOVA N.I. - Interaction of native Bowman-Birk soybean protease inhibitor and its hydrophobized derivative with multilamellar vesicles of soybean phospholipids. - Biochemistry (Moscow), 71, 103-110, 2006.
15. GREGORIADIS G. - Engineering liposomes for drug delivery: progress and problems. - Trends Biotechnol., 13, 527-537, 1995.
16. FELNEROVA D., VIRET J.-F., GLÜCK R. and MOSER C. -Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. - Curr. Opinion Biotechnol., 15, 518-529, 2004.
17. MARTYNOVA O.M., TIOURINA O.P., SELISCHEVA A.A., SOROKOUMOVA G.M., SHVETS V.I., LARIONOVA N.I. - Interaction of trypsin with multilamellar vesicles of soybean lipids. - Biochemistry (Moscow), 65, 1049-1054, 2000.
18. TIOURINA O.P., SHARP T.V., SELISCHEVA A.A., SOROKOUMOVA G.M., SHVETS V.I., LARIONOVA N.I. - Complexing of Basic Pancreatic Proteinase Inhibitor with soybean multilamellar vesicles. - Biochemistry (Moscow), 66, 340-344, 2001.
19. TIOURINA O., SHARF T., BALKINA A., OLLIVON M., SELISCHEVA A.A., SOROKOUMOVA G.M., LARIONOVA N.I. - Interaction of the water-soluble protein aprotinin with liposomes: gel-filtration, turbidity studies and 31P NMR studies. - J. Liposome Res., 13, 213-229, 2003.
20. REISFELD R. A., LEWIS U. J. and WILLIAMS D. E. - Disk electrophoresis of basic proteins and peptides on polyacrylamide gels. - Nature, 195, 281-283, 1962.
21. RODRIGUEZ-VICO F., MARTINEZ-CAYUELA M., GARCIA-PEREGRIN E., RAMIREZ H. - A procedure for eliminating interferences in the Lowry method of protein determination. - Anal. Biochem., 183, 275-278, 1989.
22. ROUSER G., FLEISCHER S., YAMAMOTO A. - Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. - Lipids, 5, 494-496, 1970.
23. De BONY J., TOCANNE J.F. - Synthesis and physical properties of phosphatidy lcholine labelled with 9-(2-anthryl)nonanoic acid, a new fluorescent probe. - Chem. Phys. Lipids, 32, 105-121, 1983.
24. MCHEDLOV-PETROSSYAN N.O., VODOLAZKAYA N.A., DOROSHENKO A.O. - Ionic equilibria of fluorophores in organized solutions: the influence of micellar microenvironment of protolytic and photophysical properties of Rhodamine B. - J. Fluorescence, 13, 235-247, 2003.
25. LAKOWlCZ J.R. - Principles of fluorescence microscopy. - 2-nd Ed., Kluwer Academic/Plenum, N.Y., 1999, 698 p.
26. RANGE M., BYRD R. A. - Obtaining high-fidelity spin-1/2 powder spectra in anisotropic media: phase-cycled Hahn echo spectroscopy. - J. Magn. Resonance, 52, 221-240, 1982.
27. COLLETIER J.P., CHAIZE B., WINTERHALTER M., FOURNIER D. - Protein encapsulation in liposomes: efficiently depends on interactions between protein and phospholipid bilayer. - BMC Biotechnol., 2, 29-34, 2002.
28. ABRAHAM S.A., MCKENZIE C., MASIN D., NG R., HARASYM T.O., MAYER L.D., BALLY M.B. - In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading. - Clin. Cancer Res., 10, 728-738, 2004.
29. MARTIN C., SOMAVARAPU S., ALPAR H.O. - Mucosal delivery of diphtheria toxoid using polymer-coated-bioadhesive liposomes as vaccine carriers. - J. Drug Del. Sci. Tech., 15, 301-306, 2005.
30. VOSS R.H., ERMLER U., ESSEN L.O., WENZL G., KIM Y.M., FLECKER P. - Crystal structure of the bifunctional soybean Bowman-Birk inhibitor at 0.28-nm resolution. Structural peculiarities in a folded protein conformation. - Eur. J. Biochem., 242, 122-131, 1996.
31. WERNER M.H., WEMMER D.E. - Identification of a protein-binding surface by differential amide hydrogen-exchange measurements. Application to Bowman-Birk serine-protease inhibitor. - Biochemistry, 30, 3356-3364, 1991.
32. LITZINGER D.C., HUANG L. - Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. - Biochim. Biophys. Acta, 1113, 201-227, 1992.
33. DRUMMOND D.C., MEYER O., HONG K., KIRPOTIN D.B., PAPAHADJOPOULOS D. - Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. - Pharm. Rev., 51, 691-743, 1999.
34. STAHELIN R.V., CHO W. - Differential roles of ionic, aliphatic and aromatic residues in membrane-protein interactions: a surface plasmon resonance study on phospholipases A2. - Biochemistry, 40, 4672-4678, 2001.
35. ZHANG L., ROZEK A., HANCOCK R.E. - Interaction of cationic antimicrobial peptides with model membranes. - J. Biol. Chem., 276, 35714-35722, 2001.
36. SEDDON J.M. - Structure of the inverted hexagonal (HII) phase and non-lamellar phase transitions of lipids. - Biochim. Biophys. Acta, 1031, 1-69, 1990.
37. PATERNOSTRE M.-T., ROUX M. and RIGAUD J.-L. - Mechanisms of membrane protein insertion into liposomes during reconstitution procedures involving the use of detergents. 1. Solubilization of large unilamellar proteoliposomes (prepared by reverse-phase evaporation) by triton X-100, octyl glucoside and sodium cholate. - Biochemistry, 27, 2668-2677, 1988.
38. KONDURI K.S., NANDEDKAR S., DÜZGÜNES N, SUZARA V., ARTWOHL J., BUNTE R., GANGADHARAM P.R.J. - Efficacy of liposomal budesonide in experimental asthma. J. Allergy Clin. Immunol., 111, 321-327, 2003.
39. WALDREP J.C., GILBERT B.E., KNIGHT C.M., BLANCK M.B., SCHERER P.W., KNIGHT V., ESCHENBACHER W. - Pulmonary delivery of beclomethasone liposome aerosol in volunteers: tolerance and safety. - Chest, 111, 316-323, 1997.
40. PETTENAZZO A., JOBE A., IKEGAMI M., ABRA R., HOGUE E., MIHALKO P. - Clearance of phosphatidylcholine and cholesterol from liposomes, liposomes loaded with metaproterenol and rabbit surfactant from adult rabbit lungs. - Am. Rev. Respir. Dis., 139, 752-758, 1989.
41. SAARI S.M., VIDGREN M.T., KOSKINEN M.O., TURJANMAA V.M.H., WALDREP J.C., NIEMINEN M.M. - Regional lung deposition and clearance of 99mTc labelled beclomethasone-DLPC liposomes in mild and severe asthma. - Chest, 113, 1573-1579, 1998.
42. TAIRA M.C., CHIARAMONI N.S., PECUCH K.M., ALONSO-ROMANOWSKI S. - Stability of liposomal formulations in physiological conditions for oral drug delivery. - Drug. Deliv., 11, 123-128, 2004.